tiprankstipranks
Genscript Biotech (HK:1548)
:1548
Hong Kong Market
1548
Genscript Biotech
RESEARCH TOOLSreports
Want to see HK:1548 full AI Analyst Report?

Genscript Biotech (1548) Ratios

10 Followers

Genscript Biotech Ratios

HK:1548's free cash flow for Q4 2025 was $0.53. For the 2025 fiscal year, HK:1548's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.47 1.47 2.72 4.76 3.23
Quick Ratio
 1.41 1.41 2.62 4.65 3.12
Cash Ratio
 0.24 0.24 0.43 2.92 1.88
Solvency Ratio
 -0.54 -0.54 3.17 -0.02 -0.15
Operating Cash Flow Ratio
 0.45 0.45 0.25 -0.58 -0.22
Short-Term Operating Cash Flow Coverage
 0.70 0.70 0.85 -5.03 -3.57
Net Current Asset Value
$ 180.58M$ 180.58M$ -119.93M$ 1.01B$ 581.24M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.11 0.14 0.12 0.14
Debt-to-Equity Ratio
 0.13 0.13 0.17 0.30 0.35
Debt-to-Capital Ratio
 0.12 0.12 0.14 0.23 0.26
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.12 0.17 0.21
Financial Leverage Ratio
 1.23 1.23 1.22 2.44 2.52
Debt Service Coverage Ratio
 0.54 0.53 0.70 -3.00 -8.21
Interest Coverage Ratio
 31.48 14.74 1.16 0.95 -33.02
Debt to Market Cap
 0.13 0.14 0.24 0.07 0.04
Interest Debt Per Share
 0.24 0.25 0.34 0.21 0.17
Net Debt to EBITDA
 1.10 1.10 8.40 4.13 1.73
Profitability Margins
Gross Profit Margin
57.65%57.65%45.77%32.24%48.60%
EBIT Margin
26.60%26.60%1.56%-38.53%-70.00%
EBITDA Margin
33.10%33.10%11.85%-29.71%-62.18%
Operating Profit Margin
26.60%26.60%1.56%3.12%-70.02%
Pretax Profit Margin
-49.04%-49.04%-28.73%-41.81%-68.99%
Net Profit Margin
-55.53%-55.53%498.22%-11.37%-36.26%
Continuous Operations Profit Margin
-55.49%-55.49%-29.23%19.40%-68.40%
Net Income Per EBT
113.24%113.24%-1734.15%27.20%52.55%
EBT Per EBIT
-184.34%-184.34%-1840.09%-1339.92%98.53%
Return on Assets (ROA)
-10.98%-10.98%56.11%-2.82%-8.91%
Return on Equity (ROE)
-12.72%-13.46%68.54%-6.86%-22.45%
Return on Capital Employed (ROCE)
6.18%6.18%0.19%0.91%-21.90%
Return on Invested Capital (ROIC)
5.55%5.55%0.18%0.89%-22.50%
Return on Tangible Assets
-11.01%-11.01%56.27%-2.84%-9.00%
Earnings Yield
-14.47%-15.41%107.38%-1.86%-3.40%
Efficiency Ratios
Receivables Turnover
 7.17 7.17 5.01 3.84 6.00
Payables Turnover
 11.05 11.05 10.80 7.25 5.77
Inventory Turnover
 10.26 10.26 10.37 5.43 5.37
Fixed Asset Turnover
 1.54 1.54 1.00 1.12 1.00
Asset Turnover
 0.20 0.20 0.11 0.25 0.25
Working Capital Turnover Ratio
 2.10 2.22 0.50 0.55 0.51
Cash Conversion Cycle
 53.46 53.46 74.31 112.00 65.57
Days of Sales Outstanding
 50.94 50.94 72.89 95.14 60.83
Days of Inventory Outstanding
 35.56 35.56 35.21 67.18 68.02
Days of Payables Outstanding
 33.04 33.04 33.78 50.32 63.28
Operating Cycle
 86.50 86.50 108.10 162.32 128.85
Cash Flow Ratios
Operating Cash Flow Per Share
 0.15 0.15 0.03 -0.14 -0.06
Free Cash Flow Per Share
 0.11 0.11 -0.03 -0.21 -0.16
CapEx Per Share
 0.04 0.04 0.07 0.07 0.10
Free Cash Flow to Operating Cash Flow
 0.74 0.74 -0.96 1.55 2.80
Dividend Paid and CapEx Coverage Ratio
 3.88 3.88 0.51 -1.82 -0.56
Capital Expenditure Coverage Ratio
 3.88 3.88 0.51 -1.82 -0.56
Operating Cash Flow Coverage Ratio
 0.62 0.62 0.10 -0.69 -0.34
Operating Cash Flow to Sales Ratio
 0.34 0.34 0.13 -0.34 -0.19
Free Cash Flow Yield
6.55%6.99%-2.62%-8.66%-5.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -6.91 -6.49 0.93 -53.79 -29.40
Price-to-Sales (P/S) Ratio
 3.85 3.60 4.64 6.12 10.66
Price-to-Book (P/B) Ratio
 0.93 0.87 0.64 3.69 6.60
Price-to-Free Cash Flow (P/FCF) Ratio
 15.27 14.31 -38.16 -11.55 -19.83
Price-to-Operating Cash Flow Ratio
 11.31 10.62 36.46 -17.90 -55.44
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 -0.03 0.91 0.76
Price-to-Fair Value
 0.93 0.87 0.64 3.69 6.60
Enterprise Value Multiple
 12.72 11.99 47.57 -16.46 -15.41
Enterprise Value
 4.04B 3.81B 3.35B 4.11B 6.00B
EV to EBITDA
 12.72 11.99 47.57 -16.46 -15.41
EV to Sales
 4.21 3.97 5.64 4.89 9.58
EV to Free Cash Flow
 16.71 15.75 -46.35 -9.23 -17.82
EV to Operating Cash Flow
 12.41 11.70 44.28 -14.31 -49.84
Tangible Book Value Per Share
 1.82 1.83 1.98 0.96 0.64
Shareholders’ Equity Per Share
 1.82 1.83 1.98 0.66 0.48
Tax and Other Ratios
Effective Tax Rate
 -0.13 -0.13 -0.02 -0.01 <0.01
Revenue Per Share
 0.44 0.44 0.27 0.40 0.30
Net Income Per Share
 -0.24 -0.25 1.36 -0.05 -0.11
Tax Burden
 1.13 1.13 -17.34 0.27 0.53
Interest Burden
 -1.84 -1.84 -18.40 1.09 0.99
Research & Development to Revenue
 0.07 0.07 0.09 0.52 0.62
SG&A to Revenue
 0.24 0.24 0.34 0.25 0.29
Stock-Based Compensation to Revenue
 0.02 0.02 0.03 0.07 0.10
Income Quality
 -0.69 -0.69 0.03 0.82 0.53
Currency in USD